Verition Fund Management’s Tectonic Therapeutic TECX Stock Holding History
Bought
Maintained
Sold
Other funds holding TECX
DTC
EC
FCM
5VM
PM
BG
WP
IC
Verition Fund Management's TECX Position: Q1 2025 in Review
Verition Fund Management sold out of Tectonic Therapeutic (TECX) in Q1 2025, closing a stake of 26,171 shares — an estimated $1.21M sold.
Verition Fund Management first reported a position in TECX in Q1 2024 and held it in 4 quarters. The position peaked at $3.48M in Q3 2024. 78 funds tracked by Wall St. Rank hold TECX as of Q1 2025.
- Verition Fund Management reported no remaining Tectonic Therapeutic position as of Q1 2025 after selling out during the quarter.
- Verition Fund Management sold 26,171 Tectonic Therapeutic shares in Q1 2025, an estimated $1.21M.
- Verition Fund Management first reported a position in Tectonic Therapeutic in Q1 2024 and held it in 4 quarters.
- Verition Fund Management's Tectonic Therapeutic position peaked at $3.48M in Q3 2024.
- 78 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2025.
Based on Verition Fund Management's 13F filing for Q1 2025, filed 15 May 2025.